½ÃÀ庸°í¼­
»óǰÄÚµå
1824200

¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ¿¹Ãø(2025-2030³â)

Global Patient Monitoring Devices Market - Forecasts from 2025 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Knowledge Sourcing Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 142 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ±Ô¸ð

ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº CAGR 7.92%·Î, 2025³â 505¾ï 5,300¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 740¾ï 400¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡´Â ȯÀÚÀÇ °Ç°­ ¸Å°³º¯¼ö¸¦ Àå±â°£ Áö¼ÓÀûÀ¸·Î °üÂûÇϰí ÃøÁ¤Çϱâ À§ÇØ ¼³°èµÈ ÀÇ·á±â±â°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ ±â±âµéÀº ¼¾¼­, µð½ºÇ÷¹ÀÌ ½Ã½ºÅÛ, ¹ø¿ª±â, Åë½Å ¸µÅ©¸¦ ÅëÇÕÇÏ¿© »ýü ½ÅÈ£¿Í Áúº´ »óŸ¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ°í ´Ù¾çÇÑ ÀÓ»ó ÇöÀå¿¡¼­ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÏ´Â µ¥ ÇʼöÀûÀÎ Åø·Î ÀÛ¿ëÇÕ´Ï´Ù.

½ÃÀå ±â¹Ý ¹× ±â¼ú ±¸¼º ¿ä¼Ò

ȯÀÚ ¸ð´ÏÅ͸µ ±â±â´Â ¿©·¯ ±â¼ú ±¸¼º ¿ä¼Ò¸¦ ü°èÀûÀ¸·Î ÅëÇÕÇÏ¿© Áö¼ÓÀûÀÎ °Ç°­ ¸Å°³ º¯¼ö¸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ±â´ÉÀ» ¼öÇàÇÕ´Ï´Ù. ÇÙ½É ¾ÆÅ°ÅØÃ³¿¡´Â µ¥ÀÌÅÍ ¼öÁýÀ» À§ÇÑ Ã·´Ü ¼¾¼­, Á¤º¸ ½Ã°¢È­¸¦ À§ÇÑ µð½ºÇ÷¹ÀÌ ÀåÄ¡, µ¥ÀÌÅÍ Ã³¸®¸¦ À§ÇÑ ½ÅÈ£ º¯È¯±â, ÀÇ·áÁø¿¡°Ô Á¤º¸¸¦ Àü¼ÛÇϱâ À§ÇÑ Åë½Å ¸µÅ©°¡ Æ÷ÇԵ˴ϴÙ.

ÀÌ ±â¼úÀº ½ÉÀå ±â´É Æò°¡¸¦ À§ÇÑ ½ÉÀå ¸ð´ÏÅ͸µ, È£Èí ÆÐÅÏ ºÐ¼®À» À§ÇÑ È£Èí ¸ð´ÏÅ͸µ, ³ú Ȱµ¿ Æò°¡¸¦ À§ÇÑ ½Å°æ ¸ð´ÏÅ͸µ, »ê¸ð ¹× žÆÀÇ °Ç°­ °üÂûÀ» À§ÇÑ Ãâ»ê ¸ð´ÏÅ͸µ µî ´Ù¾çÇÑ ¸ð´ÏÅ͸µ ¿ëµµ¸¦ Áö¿øÇÕ´Ï´Ù. ÀÌ Á¾ÇÕÀûÀÎ ¸ð´ÏÅ͸µ ±â´ÉÀº ¿©·¯ ÀÓ»ó Àü¹® ºÐ¾ß¿Í ȯÀÚ Ä¡·áÀÇ ¿ä±¸ »çÇ×À» ÃæÁ·ÇÕ´Ï´Ù.

ÀÇ·á¿ë ¸ð´ÏÅ͸µ¿¡´Â Å©°Ô µÎ °¡Áö ÀÛµ¿ ¸ðµå°¡ ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ¹ÙÀÌÅ» »çÀÎ ÃßÀûÀ» À§ÇÑ Ä§´ë ¿· ¸ð´ÏÅ͸¦ ÅëÇÑ ¿¬¼Ó ÃøÁ¤°ú ´ç´¢º´ °ü¸®¸¦ À§ÇÑ Ç÷´ç ÃøÁ¤±â µî ÈÞ´ë¿ë ±â±â¸¦ ÅëÇÑ Á¤±âÀûÀÎ °Ë»çÀÔ´Ï´Ù. ÀÌ·¯ÇÑ À¯¿¬¼ºÀ» ÅëÇØ º´¿øÀ» ±â¹ÝÀ¸·Î ÇÑ ÁýÁß ¸ð´ÏÅ͸µ°ú ÀÚÅÿ¡ ±â¹ÝÀ» µÐ ȯÀÚ ÀÚ°¡ °ü¸® ¿ëµµ¸¦ ¸ðµÎ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎ

³ëÀÎÀÇ ¸¸¼ºÁúȯ°ú ³ëÈ­¿¡ µû¸¥ °Ç°­ ÇÕº´Áõ Áõ°¡·Î ÀÎÇØ º¸´Ù ºó¹øÇϰí ÁýÁßÀûÀÎ °Ç°­ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇϱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Àα¸ Ãß¼¼´Â ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡¼­ ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù.

´ç´¢º´, ½ÉÇ÷°ü Áúȯ, ºñ¸¸ °ü·Ã Áúȯ°ú °°Àº »ýȰ½À°üº´ Áõ°¡´Â Áúº´ÀÇ ÁøÇà°ú Ä¡·á È¿°ú¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÇ Çʿ伺À¸·Î ÀÎÇØ ½ÃÀåÀÇ Å« ÆøÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¸¸¼ºÁúȯÀº ÀÓ»ó ¹× °¡Á¤ ȯ°æ ¸ðµÎ¿¡¼­ ȯÀÚ ¸ð´ÏÅ͸µ ±â±â°¡ ÃËÁøÇÏ´Â Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ÀçÅà ȯÀÚ ¸ð´ÏÅ͸µ ±â¼úÀÇ ¹ßÀüÀº ¿ø°Ý ȯÀÚ Ä¡·á¸¦ °¡´ÉÇÏ°Ô Çϰí, ÀÇ·á½Ã¼³ÀÇ ºÎ´ãÀ» ÁÙ¿© »õ·Î¿î ½ÃÀå ±âȸ¸¦ âÃâÇÕ´Ï´Ù. ÀçÅà ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀº ÀÇ·áÁø¿¡°Ô ÀÓ»óÀû ÀÇ»ç°áÁ¤À» À§ÇÑ Áö¼ÓÀûÀΠȯÀÚ µ¥ÀÌÅ͸¦ Á¦°øÇϸ鼭 °í·ÉÈ­ »çȸ¿¡ ´ëÀÀÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.

¿©·¯ Áö¿ªÀÇ Á¤ºÎ ÀÇ·áºñ Áõ°¡´Â ÀÇ·á ÀÎÇÁ¶ó Á¤ºñ¿Í ±â¼ú µµÀÔ °­È­¸¦ ÅëÇØ ½ÃÀå È®´ë¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù. °øÁß º¸°Ç¿¡ ´ëÇÑ ÅõÀÚ´Â º´¿ø, Áø·á¼Ò, Áö¿ª º¸°Ç¼Ò¸¦ À§ÇÑ Ã·´Ü ¸ð´ÏÅ͸µ ±â±âÀÇ Á¶´ÞÀ» ÃËÁøÇÕ´Ï´Ù.

ÀÇ·á Á¦°ø ¸ðµ¨ÀÇ ÁøÈ­·Î ÀÎÇØ °¡¼ÓÈ­µÇ°í ÀÖ´Â ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ Ãß¼¼´Â ¿ø°Ý Æò°¡ ¹× °³ÀÔÀ» À§ÇØ ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ȯÀÚ µ¥ÀÌÅ͸¦ Àü¼ÛÇÒ ¼ö ÀÖ´Â ±â±â¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ÀÌ ±â´ÉÀ» ÅëÇØ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» ÅëÇØ ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ°í º´¿ø ÀçÀÔ¿øÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

Áö¿ªº° ½ÃÀå ºÐÆ÷ ¹× Áö¿ªº° ¿ªÇÐ

¹ÌÁÖ¿Í À¯·´Àº Àα¸ °í·ÉÈ­¿Í »ýȰ½À°üº´ÀÇ ³ôÀº À¯º´·üÀ» ÁÖ¿ä ¿äÀÎÀ¸·Î °­·ÂÇÑ ½ÃÀå ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. À̵é Áö¿ªÀº Àß ±¸ÃàµÈ ÀÇ·á ÀÎÇÁ¶ó, Á¾ÇÕÀûÀÎ ÀÇ·áºñ »óȯ Á¦µµ, ÇÁ¸®¹Ì¾ö ¸ð´ÏÅ͸µ ±â±âÀÇ »ç¿ëÀ» Áö¿øÇÏ´Â ³ôÀº ±â¼ú µµÀÔ·ü µîÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀº °¡Ã³ºÐ ¼Òµæ ¼öÁØ Çâ»ó°ú Àα¸ Áõ°¡ÀÇ ¿ªµ¿¼ºÀ» ÅëÇØ Å« ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÇ·á ÀνÄÀÇ Çâ»ó, ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±, Áß»êÃþ Àα¸ Áõ°¡·Î ȯÀÚ ¸ð´ÏÅ͸µ ±â±â µµÀÔ¿¡ À¯¸®ÇÑ Á¶°ÇÀÌ Á¶¼ºµÇ°í ÀÖ½À´Ï´Ù.

Áö¿ªº° ½ÃÀå µ¿ÇâÀº ÀÇ·á½Ã½ºÅÛÀÇ ¼º¼÷µµ¿¡ µû¶ó ´Ù¸£¸ç, ¼±Áø±¹ ½ÃÀå¿¡¼­´Â ÷´Ü ¸ð´ÏÅ͸µ ±â´É°ú ÀçÅÃÀÇ·á ¼Ö·ç¼Ç¿¡ ÁßÁ¡À» µÎ°í, ½ÅÈï ½ÃÀå¿¡¼­´Â ±âº»ÀûÀÎ ¸ð´ÏÅ͸µ ±â´É°ú ÀÇ·á Á¢±Ù¼º È®´ë¿¡ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀΰú µµÀÔ °úÁ¦

¼±Áø±¹¿¡¼­´Â ÀÇ·á½Ã¼³ÀÌ ÃÖÀûÀÇ ¸ð´ÏÅ͸µ ±â±â ¹Ðµµ¿¡ µµ´ÞÇÔ¿¡ µû¶ó ½ÃÀå °³¹ßÀÌ Æ÷È­»óÅ¿¡ À̸£·¯ ¼ºÀå¿¡ ÇѰ谡 ÀÖ½À´Ï´Ù. ¼º¼÷ÇÑ ÀÇ·á ½ÃÀå¿¡¼­´Â »õ·Î¿î ½ÃÀå ħÅõº¸´Ù´Â ±³Ã¼ ÁÖ±â¿Í Á¡ÁøÀûÀÎ ±â¼ú °³¼±ÀÌ ÁÖ¿ä ÃËÁø¿äÀÎÀÌ µË´Ï´Ù.

ºñÈ¿À²ÀûÀÎ »óȯ ±ÔÁ¦´Â ¸ð´ÏÅ͸µ ¼­ºñ½º ¹× Àåºñ Á¶´ÞÀÇ Àû¿ë ¹üÀ§¸¦ Á¦ÇÑÇÔÀ¸·Î½á Àåºñ µµÀÔÀÇ À庮ÀÌ µË´Ï´Ù. º¹ÀâÇÑ »óȯ °úÁ¤°ú °¡º¯ÀûÀÎ º¸Çè Àû¿ë Á¤Ã¥Àº ƯÈ÷ »õ·Î¿î ¸ð´ÏÅ͸µ ±â¼ú ¹× ÀçÅÃÄ¡·á ¿ëµµ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ð´ÏÅ͸µ ±â±â¿Í ±âÁ¸ ÀÇ·á¿ë IT ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀÌ º¹ÀâÇÏ¿© µµÀÔ¿¡ ¾î·Á¿òÀÌ ÀÖÀ¸¸ç, º¸±Þ·üÀÌ µÐÈ­µÉ ¼ö ÀÖ½À´Ï´Ù. »óÈ£ ¿î¿ë¼º ¿ä±¸ »çÇ×°ú µ¥ÀÌÅÍ º¸¾È¿¡ ´ëÇÑ °í·Á»çÇ×Àº Àåºñ ¼±Åðú ¹èÄ¡ °áÁ¤¿¡ º¹À⼺À» °¡Á®¿É´Ï´Ù.

±â¼úÀÇ ÁøÈ­¿Í ½ÃÀå µ¿Çâ

°¡Ä¡ ±â¹Ý Ä¡·á·Î ÀÇ·á ¼­ºñ½º Á¦°ø ¸ðµ¨ÀÌ º¯È­ÇÔ¿¡ µû¶ó ÃøÁ¤ °¡´ÉÇÑ È¯ÀÚ °á°ú °³¼±°ú ºñ¿ë Àý°¨ ´É·ÂÀ» ÀÔÁõÇÏ´Â ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¹æ ÀÇ·á ¹× Á¶±â °³ÀÔ Àü·«À» Áö¿øÇÏ´Â ±â±â´Â ÁøÈ­ÇÏ´Â ÀÇ·áºñ ÁöºÒ ¸ðµ¨¿¡ ºÎÇÕÇÕ´Ï´Ù.

ÀΰøÁö´É°ú ¸Ó½Å·¯´× ±â´ÉÀ» ¸ð´ÏÅ͸µ ±â±â¿¡ ÅëÇÕÇÔÀ¸·Î½á ÀÇ·áÁøÀÇ ¾÷¹« ºÎ´ãÀ» ÁÙÀ̸鼭 ÀÓ»óÀû ÀÇ»ç°áÁ¤À» °­È­ÇÒ ¼ö ÀÖ´Â ¿¹Ãø ºÐ¼® ¹× ÀÚµ¿ °æ°í ½Ã½ºÅÛÀÇ ±âȸ¸¦ âÃâÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼ÒÇüÈ­ ¹× ¿þ¾î·¯ºí ±â¼úÀÇ ¹ßÀüÀº ÀÓ»óÀû Á¤È®¼º°ú ½Å·Ú¼ºÀ» À¯ÁöÇϸ鼭 ȯÀÚÀÇ Æí¾ÈÇÔ°ú ÄÄÇöóÀ̾𽺸¦ Çâ»ó½ÃŰ´Â ´ú ħ½ÀÀûÀÎ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

¾÷°èÀÇ Àü·«Àû Á߿伺

ÀÇ·á ±â¼ú Àü¹®°¡µé¿¡°Ô ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ¸¸¼ºÁúȯ °ü¸®, °í·ÉÈ­ »çȸ ´ëÀÀ, ÀÇ·á Á¦°ø ¸ðµ¨ÀÇ ÁøÈ­°¡ ±³Â÷ÇÏ´Â ºñÁî´Ï½º ±âȸÀÔ´Ï´Ù. ¼º°øÇϱâ À§Çؼ­´Â ´Ù¾çÇÑ ÀÓ»óÀû ¿ä±¸»çÇ×À» ÃæÁ·ÇÏ´Â µ¿½Ã¿¡ ºñ¿ë¿¡ ´ëÇÑ °í·Á¿Í º¹ÀâÇÑ »óȯÀ» °ü¸®ÇØ¾ß ÇÕ´Ï´Ù.

ÀçÅà ¸ð´ÏÅ͸µ ¹× ¿ø°Ý ȯÀÚ Ä¡·á ½ÃÀå °³¹ßÀº ÀÇ·á Á¦°ø Ç÷§Æû, ÀÓ»ó ¿öÅ©ÇÃ·Î¿ì °ü¸® ½Ã½ºÅÛ ¹× ÀåÄ¡ ±â¼úÀ» ÅëÇÕÇÑ Á¾ÇÕÀûÀÎ ¸ð´ÏÅ͸µ »ýŰ踦 °³¹ßÇÏ´Â ±â¾÷¿¡°Ô ºñÁî´Ï½º ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÁÖ¿ä ÀåÁ¡

  • ÀλçÀÌÆ® ºÐ¼® : °í°´ ºÎ¹®, Á¤ºÎ Á¤Ã¥ ¹× »çȸ°æÁ¦Àû ¿äÀÎ, ¼ÒºñÀÚ ¼±È£µµ, »ê¾÷º°, ±âŸ ÇÏÀ§ ºÎ¹®¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÁÖ¿ä Áö¿ª»Ó¸¸ ¾Æ´Ï¶ó ½ÅÈï Áö¿ª±îÁö Æ÷°ýÇÏ´Â »ó¼¼ÇÑ ½ÃÀå ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.
  • °æÀï ±¸µµ: ¼¼°è ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇϰí ÀÖ´Â Àü·«Àû Àü·«À» ÀÌÇØÇϰí, ÀûÀýÇÑ Àü·«À» ÅëÇÑ ½ÃÀå ħÅõ °¡´É¼ºÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú ¹Ì·¡ µ¿Çâ : ¿ªµ¿ÀûÀÎ ¿äÀΰú ¸Å¿ì Áß¿äÇÑ ½ÃÀå µ¿Çâ, ±×¸®°í À̵éÀÌ ÇâÈÄ ½ÃÀå ¹ßÀüÀ» ¾î¶»°Ô Çü¼ºÇÒ °ÍÀÎÁö¿¡ ´ëÇØ ¾Ë¾Æº¾´Ï´Ù.
  • ½ÇÇà °¡´ÉÇÑ Á¦¾È: ¿ªµ¿ÀûÀΠȯ°æ ¼Ó¿¡¼­ »õ·Î¿î ºñÁî´Ï½º ½ºÆ®¸²°ú ¸ÅÃâÀ» ¹ß±¼Çϱâ À§ÇÑ Àü·«Àû ÀÇ»ç°áÁ¤¿¡ ÀλçÀÌÆ®¸¦ Ȱ¿ëÇÕ´Ï´Ù.
  • ´Ù¾çÇÑ »ç¿ëÀÚ¿¡ ´ëÀÀ: ½ºÅ¸Æ®¾÷, ¿¬±¸±â°ü, ÄÁ¼³ÅÏÆ®, Áß¼Ò±â¾÷, ´ë±â¾÷¿¡ À¯ÀÍÇÏ°í ºñ¿ë È¿À²ÀûÀÔ´Ï´Ù.

¾î¶² ¿ëµµ·Î »ç¿ëµÇ´Â°¡?

»ê¾÷ ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¿ªÀû È®Àå, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í ¿µÇâ, ½ÅÁ¦Ç° °³¹ß, °æÀïÀÇ ¿µÇâ

ºÐ¼® ¹üÀ§

  • °ú°Å µ¥ÀÌÅÍ(2022-2024³â) ¹× ¿¹Ãø µ¥ÀÌÅÍ(2025-2030³â)
  • ¼ºÀå ±âȸ, °úÁ¦, °ø±Þ¸Á Àü¸Á, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, °í°´ Çൿ, µ¿Ç⠺м®
  • °æÀï»ç Æ÷Áö¼Å´×, Àü·« ¹× ½ÃÀå Á¡À¯À² ºÐ¼®
  • ¸ÅÃâ ¼ºÀå·ü ¹× ¿¹Ãø ºÐ¼® : ºÎ¹®º°/Áö¿ªº°(±¹°¡º°)
  • ±â¾÷ ÇÁ·ÎÆÄÀϸµ(Àü·«, Á¦Ç°, À繫Á¤º¸, ÁÖ¿ä µ¿Çâ µî)

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå ½º³À¼ô

  • ½ÃÀå °³¿ä
  • ½ÃÀåÀÇ Á¤ÀÇ
  • ºÐ¼® ¹üÀ§
  • ½ÃÀå ¼¼ºÐÈ­

Á¦3Àå ºñÁî´Ï½º »óȲ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • Porter's Five Forces ºÐ¼®
  • ¾÷°èÀÇ ¹ë·ùüÀÎ ºÐ¼®
  • Á¤Ã¥°ú ±ÔÁ¦
  • Àü·«Àû Á¦¾È

Á¦4Àå ±â¼ú Àü¸Á

Á¦5Àå ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : À¯Çüº°

  • ¼­·Ð
  • Ç÷ÇൿÅ ¸ð´ÏÅ͸µ ±â±â
  • ¸ÖƼÆÄ¶ó¹ÌÅÍ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º
  • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â±â
  • ½Å°æ ¸ð´ÏÅ͸µ ±â±â
  • üÁß ¸ð´ÏÅ͸µ µð¹ÙÀ̽º
  • È£Èí ¸ð´ÏÅ͸µ ±â±â
  • ¿Âµµ ¸ð´ÏÅ͸µ ±â±â
  • ½ÉÀå ¸ð´ÏÅ͸µ ±â±â
  • žơ¤½Å»ý¾Æ ¸ð´ÏÅ͸µ ±â±â
  • È£Èí ¸ð´ÏÅ͸µ ±â±â

Á¦6Àå ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ÀçÅà ÀÇ·á ¼³Á¤
  • ÀçȰ ¼¾ÅÍ
  • ±âŸ

Á¦7Àå ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Áö¿ªº°

  • ¼­·Ð
  • ºÏ¹Ì
    • À¯Çüº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù
      • ¸ß½ÃÄÚ
  • ³²¹Ì
    • À¯Çüº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
      • ºê¶óÁú
      • ¾Æ¸£ÇîÆ¼³ª
      • ±âŸ
  • À¯·´
    • À¯Çüº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
      • ¿µ±¹
      • µ¶ÀÏ
      • ÇÁ¶û½º
      • ½ºÆäÀÎ
      • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • À¯Çüº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ¾Æ¶ø¿¡¹Ì¸®Æ®
      • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • À¯Çüº°
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • Çѱ¹
      • ´ë¸¸
      • ±âŸ

Á¦8Àå °æÀï ȯ°æ°ú ºÐ¼®

  • ÁÖ¿ä ±â¾÷°ú Àü·« ºÐ¼®
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ±â¾÷ÀμöÇÕº´(M&A), ÇÕÀÇ, Çù¾÷
  • °æÀï ´ë½Ãº¸µå

Á¦9Àå ±â¾÷ °³¿ä

  • Koninklijke Philips N.V.
  • GE HealthCare Technologies Inc.
  • Medtronic plc
  • Abbott Laboratories
  • Masimo Corporation
  • Siemens Healthineers AG
  • Omron Corporation
  • Nihon Kohden Corporation
  • iRhythm Technologies, Inc.
  • Baxter International Inc.

Á¦10Àå ºÎ·Ï

  • ÅëÈ­
  • ÀüÁ¦Á¶°Ç
  • ±âÁØ¿¬µµ¿Í ¿¹Ãø¿¬µµ ŸÀÓ¶óÀÎ
  • ÀÌÇØ°ü°èÀÚ¿¡ ´ëÇÑ ÁÖ¿ä ÀÌÁ¡
  • ºÐ¼® ¹æ¹ý
  • ¾à¾î

µµÇ¥ ¸®½ºÆ®

Ç¥ ¸®½ºÆ®

KSA

Patient Monitoring Devices Market Size:

The Patient Monitoring Devices Market is expected to grow from USD 50.553 billion in 2025 to USD 74.004 billion in 2030, at a CAGR of 7.92%.

The patient monitoring devices market encompasses medical equipment designed for continuous observation and measurement of patient health parameters over time. These devices integrate sensors, display systems, translators, and communication links to provide real-time monitoring of vital signs and medical conditions, serving as essential tools for healthcare delivery across various clinical settings.

Market Foundation and Technology Components

Patient monitoring devices function through the systematic integration of multiple technological components that enable continuous health parameter surveillance. The core architecture includes sophisticated sensors for data collection, display devices for information visualization, signal translators for data processing, and communication links for information transmission to healthcare providers.

The technology supports diverse monitoring applications including cardiac monitoring for heart function assessment, respiratory monitoring for breathing pattern analysis, neurological monitoring for brain activity evaluation, and childbirth monitoring for maternal and fetal health observation. This comprehensive monitoring capability addresses multiple clinical specialties and patient care requirements.

Medical monitoring serves two primary operational modes: continuous measurement through bedside monitors for real-time vital sign tracking, and periodic testing through portable devices such as glucose meters for diabetes management. This flexibility enables both hospital-based intensive monitoring and home-based patient self-management applications.

Primary Market Growth Drivers

The global aging population represents the most significant long-term driver of market expansion, as elderly populations require more frequent and intensive health monitoring due to increased prevalence of chronic conditions and age-related health complications. This demographic trend creates sustained demand for monitoring equipment across various healthcare settings.

Increasing occurrences of lifestyle diseases, including diabetes, cardiovascular disorders, and obesity-related conditions, drive substantial market growth through the need for continuous monitoring of disease progression and treatment effectiveness. These chronic conditions require ongoing surveillance that patient monitoring devices facilitate both in clinical and home environments.

Advancement in home patient monitoring technologies creates new market opportunities by enabling remote patient care and reducing healthcare facility burden. Home monitoring solutions support aging-in-place initiatives while providing healthcare providers with continuous patient data for clinical decision-making.

Government health expenditure increases across multiple regions support market expansion through enhanced healthcare infrastructure development and technology adoption initiatives. Public health investment drives procurement of advanced monitoring equipment for hospitals, clinics, and community health centers.

The trend toward remote patient monitoring, accelerated by healthcare delivery model evolution, creates sustained demand for devices capable of transmitting patient data to healthcare providers for remote assessment and intervention. This capability reduces hospital readmissions while improving patient outcomes through continuous monitoring.

Geographic Market Distribution and Regional Dynamics

The Americas and European regions demonstrate strong market growth driven primarily by aging population demographics and high prevalence of lifestyle diseases. These regions benefit from established healthcare infrastructure, comprehensive reimbursement systems, and advanced technology adoption rates that support premium monitoring device utilization.

The Asia Pacific region presents significant growth opportunities through increasing disposable income levels and population growth dynamics. Rising healthcare awareness, improving healthcare infrastructure, and expanding middle-class populations create favorable conditions for patient monitoring device adoption.

Regional market development varies based on healthcare system maturity, with developed markets focusing on advanced monitoring capabilities and home care solutions, while emerging markets emphasize basic monitoring functionality and healthcare access expansion.

Market Constraints and Implementation Challenges

Market saturation in developed countries presents growth limitations as healthcare facilities reach optimal monitoring device density. Replacement cycles and incremental technology improvements become primary drivers rather than new market penetration in mature healthcare markets.

Inefficient reimbursement regulations create barriers to device adoption by limiting coverage for monitoring services and equipment procurement. Complex reimbursement processes and variable coverage policies may constrain market growth, particularly for newer monitoring technologies and home care applications.

The complexity of integrating monitoring devices with existing healthcare IT systems creates implementation challenges that may slow adoption rates. Interoperability requirements and data security considerations add complexity to device selection and deployment decisions.

Technology Evolution and Market Trends

Healthcare delivery model transformation toward value-based care drives demand for monitoring devices that demonstrate measurable patient outcome improvements and cost reduction capabilities. Devices that support preventive care and early intervention strategies align with evolving healthcare payment models.

The integration of artificial intelligence and machine learning capabilities into monitoring devices creates opportunities for predictive analytics and automated alert systems that enhance clinical decision-making while reducing healthcare provider workload.

Miniaturization and wearable technology advancement enable less intrusive monitoring solutions that improve patient comfort and compliance while maintaining clinical accuracy and reliability.

Strategic Industry Implications

For healthcare technology professionals, the patient monitoring devices market represents opportunities at the intersection of chronic disease management, aging population care, and healthcare delivery model evolution. Success requires addressing diverse clinical requirements while managing cost considerations and reimbursement complexities.

Market evolution toward home-based monitoring and remote patient care suggests opportunities for companies developing comprehensive monitoring ecosystems that integrate device technology with healthcare delivery platforms and clinical workflow management systems.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Patient Monitoring Devices Market Segmentation:

By Type

  • Hemodynamic Monitoring Devices
  • Multiparameter Monitoring Devices
  • Remote Patient Monitoring Devices
  • Neuromonitoring Devices
  • Weight Monitoring Devices
  • Respiratory Monitoring Devices
  • Temperature Monitoring Devices
  • Cardiac Monitoring Devices
  • Fetal & Neonatal Monitoring Devices

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Rehabilitation Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PATIENT MONITORING DEVICES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Hemodynamic Monitoring Devices
  • 5.3. Multiparameter Monitoring Devices
  • 5.4. Remote Patient Monitoring Devices
  • 5.5. Neuromonitoring Devices
  • 5.6. Weight Monitoring Devices
  • 5.7. Respiratory Monitoring Devices
  • 5.8. Temperature Monitoring Devices
  • 5.9. Cardiac Monitoring Devices
  • 5.10. Fetal & Neonatal Monitoring Devices
  • 5.11. Respiratory Monitoring Devices

6. PATIENT MONITORING DEVICES MARKET BY END-USER

  • 6.1. Introduction
  • 6.2. Hospitals
  • 6.3. Ambulatory Surgical Centers
  • 6.4. Home Care Settings
  • 6.5. Rehabilitation Centers
  • 6.6. Others

7. PATIENT MONITORING DEVICES MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Type
    • 7.2.2. By End-User
    • 7.2.3. By Country
      • 7.2.3.1. USA
      • 7.2.3.2. Canada
      • 7.2.3.3. Mexico
  • 7.3. South America
    • 7.3.1. By Type
    • 7.3.2. By End-User
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
      • 7.3.3.2. Argentina
      • 7.3.3.3. Others
  • 7.4. Europe
    • 7.4.1. By Type
    • 7.4.2. By End-User
    • 7.4.3. By Country
      • 7.4.3.1. United Kingdom
      • 7.4.3.2. Germany
      • 7.4.3.3. France
      • 7.4.3.4. Spain
      • 7.4.3.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. By Type
    • 7.5.2. By End-User
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
      • 7.5.3.2. UAE
      • 7.5.3.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. By Type
    • 7.6.2. By End-User
    • 7.6.3. By Country
      • 7.6.3.1. China
      • 7.6.3.2. Japan
      • 7.6.3.3. India
      • 7.6.3.4. South Korea
      • 7.6.3.5. Taiwan
      • 7.6.3.6. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Koninklijke Philips N.V.
  • 9.2. GE HealthCare Technologies Inc.
  • 9.3. Medtronic plc
  • 9.4. Abbott Laboratories
  • 9.5. Masimo Corporation
  • 9.6. Siemens Healthineers AG
  • 9.7. Omron Corporation
  • 9.8. Nihon Kohden Corporation
  • 9.9. iRhythm Technologies, Inc.
  • 9.10. Baxter International Inc.

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key benefits for the stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES

»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦